Pandemic

|3 min read

New Software Flags Emergence of COVID-19 Variants

New surveillance technique could be used in future pandemics
Updated |3 min read

The State of Clinical Development in 2023

Increasing Phase 2 clinical trial cancellations can have a long-drawn and multifold impact on clinical research
|3 min read

Monocyte Count Predicts Lung Disease Risk in COVID-19 Patients

A simple blood test result can inform clinicians which patients with severe COVID-19 will develop long-haul lung problems
|2 min read

Treatments for Long COVID-Related Neurological Symptoms in Trials

Trials will test at least three treatments for long COVID symptoms, such as fast heart rate, dizziness, and fatigue
|3 min read

Lingering IFN-γ May Be Responsible for Long COVID Symptoms

High levels of IFN-γ persisted in some long COVID patients for up to 31 months, making it a reliable biomarker
|2 min read

Vaccination During Pregnancy Protects Newborns from COVID-19

Maternal antibodies elicited by COVID-19 vaccine and booster doses were identified in infants’ cord blood
|2 min read

COVID-19 Vaccine Lowers Mortality in Newborns of Vaccinated Women

Results are from the largest study to date on the safety of newborns whose mothers were vaccinated against COVID-19 during pregnancy
|2 min read

Overlapping Epitopes to Develop Safe, Better-Suited Vaccines

Epitopes are an alternative to mRNA and may elicit targeted immune responses quickly, cost-effectively, and safely
Updated |4 min read

A Timeline of Pandemics

How pathogens have shaped our history
|2 min read

Measles Remains a Global Threat as Vaccination Coverage Declines

Millions of children missed vaccinations during the COVID-19 pandemic, driving up the global number of cases
|2 min read

FDA Clears First At-Home COVID-19 Antigen Test

The over-the-counter at-home COVID-19 test detects positive SARS-CoV-2 infection with 89.8 percent sensitivity
|2 min read

Adjuvanted Recombinant COVID-19 Vaccine Outperforms Competitors

The GB510/AS03 vaccine elicits a stronger antibody immune response against the ancestral SARS-CoV-2 strain than ChAdOx1-S
Page 1 of 13